| 2020 |
Enlund-Cerullo M, Hauta-alus H, Valkama S, Rosendahl J, Andersson S, Mäkitie O, Holmlund-Suila E. Fibroblast growth factor 23 concentrations and modifying factors in children from age 12 to 24 months. Bone. December 2020;141:115629. |
0 |
0 |
| 2020 |
Valkama S, Holmlund-Suila E, Ireland A, Hauta-alus H, Enlund-Cerullo M, Rosendahl J, Andersson S, Mäkitie O. Peripheral quantitative computed tomography (pQCT) in 12- and 24-month-old children: practical aspects and descriptive data. Bone. December 2020;141:115670. |
1 |
0 |
| 2021 |
Fratzl-Zelman N, Wesseling-Perry K, Mäkitie RE, Blouin S, Hartmann MA, Zwerina J, Välimäki V-V, Laine CM, Välimäki MJ, Pereira RC, Mäkitie O. Bone material properties and response to teriparatide in osteoporosis due to WNT1 and PLS3 mutations. Bone. May 2021;146:115900. |
2 |
1 |
| 2020 |
Manousaki D, Kämpe A, Forgetta V, Makitie RE, Bardai G, Belisle A, Li R, Andersson S, Makitie O, Rauch F, Richards JB. Increased burden of common risk alleles in children with a significant fracture history. J Bone Miner Res. May 2020;35(5):875-882. |
0 |
0 |
| 2020 |
Mäkitie RE, Kämpe A, Costantini A, Alm JJ, Magnusson P, Mäkitie O. Biomarkers in WNT1 and PLS3 osteoporosis: altered concentrations of DKK1 and FGF23. J Bone Miner Res. May 2020;35(5):901-912. |
5 |
2 |
| 2020 |
Mäkitie RE, Hackl M, Weigl M, Frischer A, Kämpe A, Costantini A, Grillari J, Mäkitie O. Unique, gender‐dependent serum microRNA profile in PLS3 gene‐related osteoporosis. J Bone Miner Res. October 2020;35(10):1962-1973. |
2 |
0 |
| 2020 |
Skarp S, Xia J, Zhang Q, Löija M, Costantini A, Ruddock LW, Mäkitie O, Wei G, Männikkö M. Exome sequencing reveals a phenotype modifying variant in ZNF528 in primary osteoporosis with a COL1A2 deletion. J Bone Miner Res. December 2020;35(12):2381-2392. |
0 |
0 |
| 2021 |
Costantini A, Alm JJ, Tonelli F, Valta H, Huber C, Tran AN, Daponte V, Kirova N, Kwon Y, Bae JY, Chung WY, Tan S, Sznajer Y, Nishimura G, Näreoja T, Warren AJ, Cormier‐Daire V, Kim O, Forlino A, Cho T, Mäkitie O. Novel RPL13 variants and variable clinical expressivity in a human ribosomopathy with spondyloepimetaphyseal dysplasia. J Bone Miner Res. February 2021;36(2):283-297. |
0 |
0 |
| 2022 |
Costantini A, Mäkitie RE, Hartmann MA, Fratzl-Zelman N, Zillikens MC, Kornak U, Søe K, Mäkitie O. Early-onset osteoporosis: rare monogenic forms elucidate the complexity of disease pathogenesis beyond type I collagen. J Bone Miner Res. September 2022;37(9):1623-1641. |
1 |
0 |
| 2022 |
Reilly ML, Ain Nu, Muurinen M, Tata A, Huber C, Simon M, Ishaq T, Shaw N, Rusanen S, Pekkinen M, Högler W, Knapen MFCM, Born Mvd, Saunier S, Naz S, Cormier-Daire V, Benmerah A, Makitie O. Biallelic KIF24 variants are responsible for a spectrum of skeletal disorders ranging from lethal skeletal ciliopathy to severe acromesomelic dysplasia. J Bone Miner Res. September 2022;37(9):1642-1652. |
0 |
0 |
| 2022 |
Hauta-alus HH, Holmlund-Suila EM, Valkama SM, Enlund-Cerullo M, Rosendahl J, Coghlan RF, Andersson S, Mäkitie O. Collagen X biomarker (CXM), linear growth, and bone development in a vitamin D intervention study in infants. J Bone Miner Res. September 2022;37(9):1653-1664. |
0 |
0 |
| 2023 |
Bergen DJM, Maurizi A, Formosa MM, McDonald GLK, El-Gazzar A, Hassan N, Brandi M-L, Riancho JA, Rivadeneira F, Ntzani E, Duncan EL, Gregson CL, Kiel DP, Zillikens MC, Sangiorgi L, Högler W, Duran I, Mäkitie O, Van Hul W, Hendrickx G. High bone mass disorders: new insights from connecting the clinic and the bench. J Bone Miner Res. February 2023;38(2):229-247. |
0 |
0 |